(32 days)
Not Found
Not Found
No
The summary describes a liquid quality control material for manual cell counting and does not mention any computational or analytical components that would utilize AI/ML.
No
This device is a Quality Control material used to validate the quantitation of red and white blood cells in patient CSF samples, not a therapeutic device.
No
Explanation: This device is a quality control material intended for validating the quantitation of red and white blood cells, not for diagnosing patient conditions itself. It helps establish intralaboratory parameters for accuracy and precision of manual cell counting methods.
No
The device description clearly states it is a liquid control material containing stabilized human red and white blood cells, which is a physical substance, not software.
Based on the provided information, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states that the device is for "monitoring cell counts performed manually using a hemocytometer to validate quantitation of red and white blood cells in patient CSF samples." This clearly indicates its use in the examination of specimens derived from the human body (CSF) to provide information for diagnostic purposes (validating cell counts).
- Device Description: The description mentions it is "prepared in a human protein matrix fortified to target levels with purified chemicals and stabilized human red blood cells and human white blood cells." This composition is consistent with a control material used in laboratory testing.
- Quality Control Material: The intended use also states it is "intended for use as Quality Control materials having known component concentrations." Quality control materials are a fundamental part of IVD testing to ensure the accuracy and precision of the test method.
Therefore, the Quantimetrix Spinalscopics Control fits the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Quantimetrix Spinalscopics Control is intended for monitoring cell counts performed manually using a hemocytometer to validate quantitation of red and white blood cells in patient CSF samples. The Spinalscopics Control is intended for use as Quality Control materials having known component concentrations. Daily monitoring of the control values establishes intralaboratory parameters for accuracy and precision of the manual cell counting methods.
Product codes
75JJY
Device Description
Spinalscopics Spinal Fluid Cell Count Control is supplied in two levels, 3 mL per bottle. It is a ready-to-use liquid requiring no reconstitution or dilution. It is prepared in a human protein matrix fortified to target levels with purified chemicals and stabilized human red blood cells and human white blood cells. Preservatives, including sodium azide, have been added to inhibit microbial growth.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The closed vial stability claim made for this product is 1 year when stored at 2 - 8 C. The overall shelf life of the Spinalscopics control was extrapolated from accelerated stability models using elevated temperature storage to simulate real time stability. The Spinalscopics control was stored at 5 C and at 25 C to simulate 1 and 2 years storage at 2 - 8 C. Control samples were counted in duplicate hemocytometer chambers at day 0 and at 32 days and at 48 days. Control samples that were refrigerated for 32 days and 48 days were tested in duplicate hemocytometer chambers at the same time as the stressed samples for comparison. A total of 10 samples were counted in duplicate for each storage condition.
The failure criteria for stability for the recovery of cell counts for red and white blood cells was set as a decrease of greater than 15% of the mean cell recovery compared to the initial cell count or a greater than 10% decrease in the range of cells counted in 10 duplicate hemocytometer chambers. Using this criteria the cell count recovery for both red and white blood cells passed accelerated stability with either >85% mean cell recovery or equal recovery of the range of cells counted in the initial sample and at 32 days at room temperature the mean cell recovery was approximately 75% of the initial count. Therefore we have given this product a one year expiration dating. Real time stability testing is on going on multiple lots of product.
The closed vial stability claim for this product when stored at 2 - 8 C is 1 year. Real time testing and accelerated stability models were used to determine the closed vial refrigerated shelf life. To test the real time stability of the unopened control, vials were held at refrigerated temperature for 6.5 months without opening. Cell counts were compared to initial cell counts and cell counts of vials of a second lot which had been stored refrigerated unopened for four months.
The open vial stability claim for this product when stored at 2 - 8 C is 6 months. Open vial studies consisted of removing the control from the refrigerator (2 - 8 C storage) weekly, allowing it to warm to room temperature (20 - 25 C), removing an aliquot of control, followed by returning the vial to the refrigerator (2- 8 C) for storage. Testing was done on one product lot of each level of control initially and after 6.5 months of weekly opening. The RBC and WBC cell counts passed real time open vial refrigerated stability for 6.5 months with >90% recovery.
The open vial stability claim for this product when stored at room temperature (20 - 25 C) is 30 days. Real time open vial studies for this product were performed on three lots of product for each level of control. Open vial studies consisted of storing the product at room temperature (20 - 25 C) and testing the control 20 times (once per day) over a 30 day time period. The RBC and WBC cell counts passed real time open vial room temperature storage stability for 30 days with >90% recovery.
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
510(k) Summary
Prepared: March 5, 1997
APR - 8 1997
Submitted by:
Establishment Address:
Quantimetrix Corporation 2005 Manhattan Beach Boulevard Redondo Beach CA 90278 Phone: 310 536-0006 FAX: 310 536-9977
Establishment Registration Number: 2020715
Contact Person: Evy K. Johnson, Director, Technical Services & OEM
Classification Name: Multi-Analyte Control, All Kinds, Assayed and Unassayed (75JJY)
Common Name: Spinal Fluid Cell Count Control
Proprietary Name: Spinalscopics Spinal Fluid Cell Count Control
Classification: Proposed Class I
Substantial Equivalence:
The Quantimetrix Spinalscopics Spinal Fluid Cell Count Control is supplied liquid in two levels and consists of a human protein matrix containing preservatives to which reagent grade chemicals and stabilized human red and white blood cells and other human components have been added at different concentrations to achieve the two levels.
The Quantimetrix Spinalscopics controls are substantially equivalent to other such controls in general use such as the QuanTscopics Urine Microscopics Control sold by Quantimetrix Corp., which is supplied in two levels as a liquid human urine matrix to which stabilized human red blood cells and white blood cells and human protein, other chemicals and nonprotein materials have been added by the manufacturer.
Description:
Spinalscopics Spinal Fluid Cell Count Control is supplied in two levels, 3 mL per bottle. It is a ready-to-use liquid requiring no reconstitution or dilution. It is prepared in a human protein matrix fortified to target levels with purified chemicals and stabilized human red blood cells and human white blood cells. Preservatives, including sodium azide, have been added to inhibit microbial growth.
Intended Use: The Quantimetrix Spinalscopics Control is intended for monitoring cell counts performed manually using a hemocytometer to validate quantitation of red and white blood cells in patient CSF samples. The Spinalscopics Control is intended for use as Quality Control materials having known component concentrations. Daily monitoring of the control values establishes intralaboratory parameters for accuracy and precision of the manual cell counting methods.
Technological Characteristics Compared to Predicate Devices:
The Quantimetrix Spinalscopics control product employs liquid human protein matrix and a stabilized human red and white blood cell constituent formulation equivalent to the predicate device listed above. The predicate device uses a liquid human urine matrix containing human proteins. The Spinalscopics Control also has similar storage and stability requirements as the equivalent device.
Performance Characteristics:
The closed vial stability claim made for this product is 1 year when stored at 2 - 8 C. The overall shelf life of the Spinalscopics control was extrapolated from accelerated stability models using
1
elevated temperature storage to simulate real time stability. The Spinalscopics control was stored at 5 C and at 25 C to simulate 1 and 2 years storage at 2 - 8 C. Control samples were counted in duplicate hemocytometer chambers at day 0 and at 32 days and at 48 days. Control samples that were refrigerated for 32 days and 48 days were tested in duplicate hemocytometer chambers at the same time as the stressed samples for comparison. A total of 10 samples were counted in duplicate for each storage condition.
The failure criteria for stability for the recovery of cell counts for red and white blood cells was set as a decrease of greater than 15% of the mean cell recovery compared to the initial cell count or a greater than 10% decrease in the range of cells counted in 10 duplicate hemocytometer chambers. Using this criteria the cell count recovery for both red and white blood cells passed accelerated stability with either >85% mean cell recovery or equal recovery of the range of cells counted in the initial sample and at 32 days at room temperature the mean cell recovery was approximately 75% of the initial count. Therefore we have given this product a one year expiration dating. Real time stability testing is on going on multiple lots of product.
The closed vial stability claim for this product when stored at 2 - 8 C is 1 year. Real time testing and accelerated stability models were used to determine the closed vial refrigerated shelf life. To test the real time stability of the unopened control, vials were held at refrigerated temperature for 6.5 months without opening. Cell counts were compared to initial cell counts and cell counts of vials of a second lot which had been stored refrigerated unopened for four months.
The open vial stability claim for this product when stored at 2 - 8 C is 6 months. Open vial studies consisted of removing the control from the refrigerator (2 - 8 C storage) weekly, allowing it to warm to room temperature (20 - 25 C), removing an aliquot of control, followed by returning the vial to the refrigerator (2- 8 C) for storage. Testing was done on one product lot of each level of control initially and after 6.5 months of weekly opening. The RBC and WBC cell counts passed real time open vial refrigerated stability for 6.5 months with >90% recovery.
The open vial stability claim for this product when stored at room temperature (20 - 25 C) is 30 days. Real time open vial studies for this product were performed on three lots of product for each level of control. Open vial studies consisted of storing the product at room temperature (20 - 25 C) and testing the control 20 times (once per day) over a 30 day time period. The RBC and WBC cell counts passed real time open vial room temperature storage stability for 30 days with >90% recovery.
1 L. Kennon, Stability Prediction Model, Journal of Pharmaceutical Sciences 53:7, 815-818, 1964.